Calcium Entry Blockers in Cardiovascular and Cerebral Dysfunctions: Developments in Cardiovascular Medicine, cartea 40
Editat de T. Godfraind, A.G. Herman, D. Wellensen Limba Engleză Paperback – 4 noi 2011
Din seria Developments in Cardiovascular Medicine
- 5%
Preț: 1044.79 lei - 5%
Preț: 380.99 lei - 5%
Preț: 375.50 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 1048.21 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 643.30 lei - 5%
Preț: 630.82 lei - 5%
Preț: 628.80 lei - 5%
Preț: 637.41 lei - 5%
Preț: 636.74 lei - 5%
Preț: 641.94 lei - 5%
Preț: 405.96 lei - 5%
Preț: 383.16 lei - 5%
Preț: 1363.81 lei - 5%
Preț: 362.13 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 1382.39 lei - 5%
Preț: 362.47 lei - 5%
Preț: 354.38 lei - 5%
Preț: 365.81 lei - 5%
Preț: 2034.92 lei - 5%
Preț: 353.34 lei - 5%
Preț: 352.64 lei - 5%
Preț: 357.02 lei - 5%
Preț: 356.87 lei - 5%
Preț: 752.94 lei - 5%
Preț: 685.66 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 361.23 lei - 5%
Preț: 359.30 lei - 5%
Preț: 695.99 lei - 5%
Preț: 1061.25 lei - 5%
Preț: 2034.57 lei - 5%
Preț: 688.44 lei - 5%
Preț: 357.91 lei - 5%
Preț: 694.44 lei - 5%
Preț: 634.66 lei - 5%
Preț: 361.08 lei - 5%
Preț: 1367.84 lei - 5%
Preț: 687.74 lei - 5%
Preț: 760.14 lei
Preț: 385.95 lei
Preț vechi: 406.26 lei
-5% Nou
Puncte Express: 579
Preț estimativ în valută:
68.31€ • 79.94$ • 59.76£
68.31€ • 79.94$ • 59.76£
Carte tipărită la comandă
Livrare economică 19-26 ianuarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400960350
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I: Introductory considerations.- The major steps in the discovery of calcium entry blockers..- Basic mechanisms and classification of calcium entry blockers..- Calcium entry blockers: perspectives..- Twenty-seven calcium entry blockers in development: a new chapter in pharmacology..- II: Calcium entry blockers and peripheral circulatory function..- Calcium-ions and excitation contraction coupling in vascular smooth muscle cells..- Laser microprobe mass analysis (LAMMA) as a technique to quantitate Ca2+ ions..- Vascular pharmacology of calcium entry blockers..- Calcium homeostasis in human red blood cells..- Impact of Ca2+ entry blockers on Ca2+ dependent mechanisms in red blood cells, platelets and endothelial cells..- Red blood cell microrheology and calcium antagonists..- Calcium e ntry blockers in the treatment of peripheral obliterative arterial disease..- III: Calcium entry blockers and myocardial function..- Pharmacology of calcium entry blockers in animal and human coronary arteries..- Calcium paradox and calcium entry blockers..- Myocardial oxygen deprivation and calcium deprivation: ultrastructural characteristics and clinical significance..- Basic and clinical aspects of myocardial protection by calcium entry blockers..- Effect of calcium entry blockers on impaired left ventricular wall motion..- The influence of Ca2+ entry blockers on hemodynamics and coronary blood flow, and its importance for the treatment of angina pectoris..- The use of selective calcium antagonism in variant (vasospastic) and classical (effort) angina pectoris..- Calcium entry blockers in cardiovascular therapy. Influence of diltiazem on hemodynamics and coronary blood flow..- IV: Calcium entry blockers and cerebral function..- Calcium entry blockers and cerebral function: an introduction..- Calcium entry blockers and cerebral resuscitation..- Effect of calcium entry blockers in models of brain hypoxia..- Calcium entry blockers in the therapy of vertebrobasilar insufficiency..- Calcium entry blockers and pharmacological aspects of migraine..- Clinical evaluation of calcium entry blockers in migraine..- V: Calcium entry blockers in hypertension treatment..- Double-blind comparison of the antihypertensive effects of verapamil and nifedipine..- Treatment of hypertension emergencies and chronic arterial hypertension with calcium entry blockers..- The effect of nifedipine on arterial pressure and reflex cardiac control..- Concluding remarks.- Why are Ca2+ entry blockers effective in the treatment of hypertension and tissue hypoxia?.- List of authors and co-authors.